论文部分内容阅读
中国宁波天衡制药厂生产的枢丹系 5-ＨＴ3受体拮抗剂 ,是高效低毒的新型止吐药。我科自 1996年 12月～ 1999年 6月对 56例恶性肿瘤患者介入化疗 78次 ,同时动脉应用枢丹的疗效观察 ,并对 2 0例介入治疗 30次应用胃复安作为对照 ,评价不同药物对抗恶性肿瘤介入化疗后胃肠道反应
The pivotal 5-HT3 receptor antagonists produced in China’s Ningbo Tianheng Pharmaceutical Factory are highly effective and low-toxic anti-emetic drugs. In our department, from 1996 to June 1999, interventional chemotherapy for 56 patients with malignant tumors was performed 78 times. At the same time, the efficacy of arterial application of glibentan was observed, and 20 cases of interventional treatment were used as a control and metoclopramide was evaluated for 30 times. Drugs against gastrointestinal reactions after interventional chemotherapy for malignant tumors